Catalyst Wire Dossier Catalyst Wire Dossier

HD-MAP H7N9 influenza vaccine

· Vaxxas Pty Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HD-MAP H7N9 influenza vaccine, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) [Phase 1]

See pricing